about
T cell receptor mimic antibodies for cancer therapyStructure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.Solid-state NMR analysis of membrane proteins and protein aggregates by proton detected spectroscopyA TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemiasDeconvoluting hepatic processing of carbon nanotubesDual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations.Opportunities and challenges for TCR mimic antibodies in cancer therapyMechanisms of leukemia resistance to antibody dependent cellular cytotoxicity.Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome
P50
Q26768271-4E310BDF-D0FC-40A7-B271-B61C8ADE69DBQ30382749-AC4659D0-8AE9-423E-93AD-34B67A49C1E2Q30421354-F8195652-0257-4058-9F81-67CF3289DB94Q33714727-60FDA677-5882-4104-9156-04BDE86892B5Q37153829-DC5B1D17-CE96-40B9-8843-E2E7BE7A1B85Q37706739-B5C40ECA-4518-4D7E-8BFF-5C5A4115F3A8Q37711782-2A882297-3754-4FF6-A584-6E48396C8DA3Q38812269-D768F565-A122-47DD-95F7-22056C820569Q41298278-548FD1E8-6950-4864-A6F5-375B5E83D98CQ42697252-C3B0F418-EF61-4B3F-ACA9-C809B3AC33C3Q43104067-76F4CB0C-FCCB-4391-8B26-604422473209Q90196273-A1AE8DD8-FF10-4974-95A2-8036548A6097
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Elliott J Brea
@en
Elliott J Brea
@nl
type
label
Elliott J Brea
@en
Elliott J Brea
@nl
prefLabel
Elliott J Brea
@en
Elliott J Brea
@nl
P31
P496
0000-0002-6283-0267